US Patent Litigations are now available. Check here
The patent EP2897588B1 was granted on Jul 17, 2019 by Teva Branded Pharmaceutical Products R & D The patent is currently Opposition Rejected.
Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents